Francesc Marti is the Chief of the Cell Immunotherapy Program in the Transplant Center at the University of Kentucky, leading the translational research program responsible for manufacturing Treg cells for clinical application. His research is focused on cellular and molecular mechanisms controlling the plasticity in lineage fate determination of T cells, development and function of regulatory T cells, and transplant tolerance, obesity and tumor immunology.